General Information
Version
8.1
Revision date
2025-08-08
Product name
FLO-1 Cell Line human
Emergency telephone
+44 (0)870 8200418
Icons in SDS
Company Information
company name
Merck Life Science UK Limited
e-mail address of the competent person responsible for the Safety Data Sheet
TechnicalService@merckgroup.com
Section 2
SECTION 2: Hazards identification
Ingredient(s) with unknown acute toxicity
50% (oral), 90.5% (dermal), 53.9% (inhalation)
Signal word
Warning
Hazard statements
Causes skin irritation. May cause an allergic skin reaction. Causes serious eye irritation. Suspected of causing cancer. May form combustible dust concentrations in air.
Prevention
Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Wear protective gloves, protective clothing and eye or face protection. Avoid breathing dust or mist. Wash thoroughly after handling. Contaminated work clothing must not be allowed out of the workplace.
Response
IF exposed or concerned Get medical advice or attention. IF ON SKIN Wash with plenty of water. If skin irritation or rash occurs: Get medical advice or attention. Take off contaminated clothing and wash it before reuse. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. If eye irritation persists: Get medical advice or attention.
Storage
Store locked up.
Disposal
Dispose of contents and container in accordance with all local, regional, national and international regulations.
Supplemental label elements
Keep container tightly closed. Keep away from heat, sparks, open flames and hot surfaces. - No smoking. Sanding and grinding dusts may be harmful if inhaled. Prevent dust accumulation. Emits toxic fumes when heated.
2.3 Other hazards
Fine dust clouds may form explosive mixtures with air. Handling and/or processing of this material may generate a dust which can cause mechanical irritation of the eyes, skin, nose and throat.
2.1 Classification of the substance or mixture
SKIN IRRITATION - Category 2 EYE IRRITATION - Category 2A SKIN SENSITIZATION - Category 1 CARCINOGENICITY - Category 2 Percentage of the mixture consisting of ingredient(s) of unknown acute toxicity: 50% (oral), 90.5% (dermal), 53.9% (inhalation)